Category: News Well
Content tagged to appear in the middle column of the home page
Minneapolis medtech giant Medtronic implants the 1st human patient with its tiny, minimally invasive Micra Transcatheter Pacing System.
Medtech giant Medtronic (NYSE:MDT) this week announced 1st-in-human implantation of its tiny catheter-based pacemaker, the Micra Transcatheter Pacing System.
Bolton Medical launches a U.S. phase II clinical trial for its Treovance abdominal stent graft system and Navitel delivery system.
Bolton Medical launched phase II of its U.S. clinical trial for its Treovance abdominal stent graft system and corresponding Navitel delivery system.
The Treovance stent graft is designed to be adaptable and flexible in order to accommodate a wide range of anatomies. The Navitel delivery system includes a proximal clasping system for precise delivery.
The phase II study will treat 150 patients with infrarenal aortic aneurysms, enrolled at 30 institutions located throughout the U.S., according to the press release.
C4 Imaging celebrates its 1st U.S. regulatory win with 510(k) clearance for the Sirius MRI marker.
C4 Imaging won clearance from the FDA for its 1st product, the Sirius Positive Signal MRI marker, designed for use following the treatment of prostate cancer with brachytherapy.
The MRI marker is designed to facilitate seed localization within the prostate, utilizing a single post-implant MRI procedure.
Brachytherapy involves implanting around 100 radioactive seeds into the prostate. It has risen in popularity because the treatment is considered more effective and convenient, according to the press release.
Cochlear Limited wins FDA clearance for its Baha 4 Attract system, a hearing aid based on magnetic bone conduction.
Cochlear Ltd. (ASX:COH) said landed 510(k) clearance from the FDA for its Baha 4 attract system, a bone conduction hearing system.
Former Vice President Dick Cheney continues speaking out against the medtech tax, saying that the levy slows down innovations of the type that have saved his life time and again.
MASSDEVICE ON CALL — Former Vice President Dick Cheney continued to publicly criticize the medtech tax while on tour for his new book, "Heart: An American Medical Odyssey."
Cheney told the hosts of "Fox & Friends" this week that the medtech tax hampers innovation in medical technologies, and that he has relied on the industry time and again to save his life.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.